Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Semini Sumanasuriya

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cold Spring Harbor Perspectives in Medicine|November 5, 2017
Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future PromiseSemini Sumanasuriya, Johann De Bono
Trends in Pharmacological Sciences|June 13, 2018
Hypoxia and Noncoding RNAs in Taxane ResistancePerla Pucci, Pasquale Rescigno, Semini Sumanasuriya, et al.
The Journal of Pathology|October 19, 2016
The molecular underpinnings of prostate cancer: impacts on management and pathology practiceDaniel Nava Rodrigues, Gunther Boysen, Semini Sumanasuriya, et al.
Clinical Genitourinary Cancer|June 14, 2017
Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsNiven Mehra, Adam Sharp, David Lorente, et al.
Plos One|March 2, 2018
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification productsAlberto Ferrarini, Claudio Forcato, Genny Buson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2018
RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate CancerDaniel Nava Rodrigues, Nicola Casiraghi, Alessandro Romanel, et al.
European Urology Oncology|June 19, 2018
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate CancersPasquale Rescigno, David Lorente, David Dolling, et al.
European Urology|March 4, 2018
Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)Niven Mehra, David Dolling, Semini Sumanasuriya, et al.
European Urology|March 12, 2016
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate CancerPasquale Rescigno, David Lorente, Diletta Bianchini, et al.
European Urology|October 21, 2018
Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair DeficiencyZafeiris Zafeiriou, Diletta Bianchini, Robert Chandler, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cold Spring Harbor Perspectives in Medicine|November 5, 2017
Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future PromiseSemini Sumanasuriya, Johann De Bono
Trends in Pharmacological Sciences|June 13, 2018
Hypoxia and Noncoding RNAs in Taxane ResistancePerla Pucci, Pasquale Rescigno, Semini Sumanasuriya, et al.
The Journal of Pathology|October 19, 2016
The molecular underpinnings of prostate cancer: impacts on management and pathology practiceDaniel Nava Rodrigues, Gunther Boysen, Semini Sumanasuriya, et al.
Clinical Genitourinary Cancer|June 14, 2017
Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsNiven Mehra, Adam Sharp, David Lorente, et al.
Plos One|March 2, 2018
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification productsAlberto Ferrarini, Claudio Forcato, Genny Buson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2018
RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate CancerDaniel Nava Rodrigues, Nicola Casiraghi, Alessandro Romanel, et al.
European Urology Oncology|June 19, 2018
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate CancersPasquale Rescigno, David Lorente, David Dolling, et al.
European Urology|March 4, 2018
Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)Niven Mehra, David Dolling, Semini Sumanasuriya, et al.
European Urology|March 12, 2016
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate CancerPasquale Rescigno, David Lorente, Diletta Bianchini, et al.
European Urology|October 21, 2018
Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair DeficiencyZafeiris Zafeiriou, Diletta Bianchini, Robert Chandler, et al.
Pageof 3